Autori: Lip Gregory YH
| Naslov | Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry (Article) |
| Autori | Ding Wern Yew Kotalczyk Agnieszka Boriani Giuseppe Marin Francisco Blomstrom-Lundqvist Carina Potpara Tatjana S Fauchier Laurent Lip Gregory YH |
| Info | EUROPEAN JOURNAL OF INTERNAL MEDICINE, (2022), vol. 103 br. , str. 41-49 |
| Projekat | Abbott Vascular Int.; Amgen Cardiovascular; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Pfizer Alliance; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Edwards; Gedeon Richter Plc.; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; SERVIER; Vifor |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry (Article) |
| Autori | Romiti Giulio Francesco Proietti Marco Vitolo Marco Bonini Niccolo Fawzy Ameenathul Mazaya Ding Wern Yew Fauchier Laurent Marin Francisco Nabauer Michael Dan Gheorghe Andrei Potpara Tatjana S Boriani Giuseppe Lip Gregory YH |
| Info | BMC MEDICINE, (2022), vol. 20 br. 1, str. - |
| Projekat | Abbott Vascular Int; Amgen Cardiovascular; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Pfizer Alliance; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Edwards; Gedeon Richter Plc.; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; SERVIER; Vifor |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations (Article) |
| Autori | Imberti Jacopo Francesco Mei Davide Antonio Vitolo Marco Bonini Niccolo Proietti Marco Potpara Tatjana S Lip Gregory YH Boriani Giuseppe |
| Info | EUROPEAN JOURNAL OF INTERNAL MEDICINE, (2022), vol. 101 br. , str. 1-7 |
| Projekat | Medtronic; Boston; Biotronik; Boehringer; Bayer |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Epidemiology and impact of frailty in patients with atrial fibrillation in Europe (Article) |
| Autori | Proietti Marco Romiti Giulio Francesco Vitolo Marco Harrison Stephanie L Lane Deirdre A Fauchier Laurent Marin Francisco Nabauer Michael Potpara Tatjana S Dan Gheorghe-Andrei Maggioni Aldo P Cesari Matteo Boriani Giuseppe Lip Gregory YH |
| Info | AGE AND AGEING, (2022), vol. 51 br. 8, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry (Article) |
| Autori | Vitolo Marco Malavasi Vincenzo L Proietti Marco Diemberger Igor Fauchier Laurent Marin Francisco Nabauer Michael Potpara Tatjana S Dan Gheorghe-Andrei Kalarus Zbigniew Tavazzi Luigi Maggioni Aldo Pietro Lane Deirdre A Lip Gregory YH Boriani Giuseppe |
| Info | EUROPEAN JOURNAL OF INTERNAL MEDICINE, (2022), vol. 99 br. , str. 45-56 |
| Projekat | Abbott Vascular Int.; Amgen Cardiovascular; AstraZeneca; Bayer; Boeh-ringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Pfizer Alliance; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Edwards; Gedeon Richter Plc.; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; SERVIER; Vifor |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke (Article) |
| Autori | Lip Gregory YH Lane Deirdre A Lenarczyk Radoslaw Boriani Giuseppe Doehner Wolfram Benjamin Laura A Fisher Marc Lowe Deborah Sacco Ralph L Schnabel Renate Watkins Caroline Ntaios George Potpara Tatjana S |
| Info | EUROPEAN HEART JOURNAL, (2022), vol. 43 br. 26, str. 2442-2460 |
| Projekat | Wellcome Trust [222102/Z/20/Z] |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Adherence to the 4S-AF Scheme in the Balkan region: Insights from he BALKAN-AF survey (Article) |
| Autori | Koziel-Siolkowska Monika Mihajlovic Miroslav Nedeljkovic Milan A Pavlovic Nikola Paparisto Vilma Music Ljilja Trendafilova Elina Dan Anca Rodica Kusljugic Zumreta Dan Gheorghe-Andrei Lip Gregory YH Potpara Tatjana S |
| Info | KARDIOLOGIA POLSKA, (2022), vol. 80 br. 4, str. 461-467 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Outcomes of digoxin vs. beta blocker in atrial fibrillation: report from ESC-EHRA EORP AF Long-Term General Registry (Article) |
| Autori | Ding Wern Yew Boriani Giuseppe Marin Francisco Blomstrom-Lundqvist Carina Potpara Tatjana S Fauchier Laurent Lip Gregory YH |
| Info | EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, (2022), vol. 8 br. 4, str. 372-382 |
| Projekat | Abbott Vascular Int.; Amgen Cardiovascular; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Edwards; Gedeon Richter Plc.; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; SERVIER; Vifor; Pfizer Alliance |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry (Article) |
| Autori | Ding Wern Yew Proietti Marco Boriani Giuseppe Fauchier Laurent Blomstrom-Lundqvist Carina Marin Francisco Potpara Tatjana S Lip Gregory YH |
| Info | EUROPACE, (2022), vol. 24 br. 5, str. 721-728 |
| Projekat | Abbott Vascular IntAbbott Laboratories; Amgen Cardiovascular; AstraZenecaAstraZeneca; BayerBayer AG; Boehringer IngelheimBoehringer Ingelheim; Boston ScientificBoston Scientific; Bristol Myers SquibbBristol-Myers Squibb; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and CompanyEli Lilly; Edwards [2016-19]; Gedeon Richter Plc.; Menarini Int. Op.Menarini Group; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; SERVIERServier; Vifor; Pfizer Alliance |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry (Article) |
| Autori | Malavasi Vincenzo L Vitolo Marco Proietti Marco Diemberger Igor Fauchier Laurent Marin Francisco Nabauer Michael Potpara Tatjana S Dan Gheorghe-Andrei Kalarus Zbigniew Tavazzi Luigi Maggioni Aldo Pietro Lane Deirdre A Lip Gregory YH Boriani Giuseppe |
| Info | EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, (2022), vol. 52 br. 7, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
